SAMHSA Clinical Advisory: Considerations for Genetic Testing in the Assessment of Substance Use Disorder Risk

SAMHSA Clinical Advisory: Considerations for Genetic Testing in the Assessment of Substance Use Disorder Risk
This Advisory examines the role of genetic testing in assessing SUD vulnerability and outlines the current limitations of these technologies.
Authoring Agency
Substance Abuse and Mental Health Services Administration (SAMHSA)
View Resource

Last Updated: